PP
RXST icon

PDT Partners’s RxSight RXST Stock Holding History

PDT Partners’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$163K Sell
26,521
-56,318
-68% -$468K 0.01% 508
2025
Q4 		$863K Sell
82,839
-6,785
-8% -$68.1K 0.06% 359
2025
Q3 		$806K Hold
89,624
– – 0.05% 383
2025
Q2 		$1.17M Buy
+89,624
New +$1.35M 0.07% 398
2025
Q1 		– Sell
-26,245
Closed -$902K – 841
2024
Q4 		$902K Buy
26,245
+8,116
+45% +$366K 0.08% 359
2024
Q3 		$896K Buy
+18,129
New +$929K 0.08% 387

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

PDT Partners's RXST Position: Q1 2026 in Review

PDT Partners reduced its RxSight (RXST) stake by 68% in Q1 2026, selling an estimated $468K and leaving 26,521 shares worth $163K. The position accounts for 0.01% of the portfolio, ranked #508.

PDT Partners first reported a position in RXST in Q3 2024 and has held it in 6 quarters since. The position peaked at $1.17M in Q2 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • PDT Partners held 26,521 shares of RxSight worth $163K as of Q1 2026.
  • PDT Partners sold 56,318 RxSight shares in Q1 2026, an estimated $468K.
  • RxSight made up 0.01% of PDT Partners's portfolio in Q1 2026, its #508 holding.
  • PDT Partners first reported a position in RxSight in Q3 2024 and has held it in 6 quarters since.
  • PDT Partners's RxSight position peaked at $1.17M in Q2 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.